Utama › Kanser Paru-paru › Illinois › Evanston
Kajian klinikal Kanser Paru-paru di Evanston, IL
19 kajian untuk Kanser Paru-paru sedang mencari peserta di lokasi dalam dan sekitar Evanston (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Mengambil pesertaFasa 3
- NorthShore University HealthSystem-Evanston Hospital, Evanston
- NorthShore University HealthSystem-Glenbrook Hospital, Glenview · 5 mi jauh
- Advocate Lutheran General Hospital, Park Ridge · 8 mi jauh
- dan 1 lagi
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Advocate Lutheran General Hospital, Park Ridge · 8 mi jauh
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Mengambil pesertaFasa 3
- Advocate Lutheran General Hospital, Park Ridge · 8 mi jauh
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Mengambil pesertaFasa 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi jauh
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Mengambil pesertaFasa 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi jauh
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Mengambil pesertaFasa 3
- North Shore University Health System ( Site 4014), Evanston
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Mengambil pesertaFasa 3
- Illinois Cancer Specialists, Niles · 6 mi jauh
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Mengambil pesertaFasa 3
- Illinois Cancer Specialists, Niles · 6 mi jauh
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Mengambil pesertaFasa 3
- Advocate Lutheran General Hospital, Park Ridge · 8 mi jauh
A Registry for People With Lung Cancer
Mengambil pesertaKajian pemerhatian
- Endeavor Health, Evanston
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Mengambil pesertaFasa 3
- Illinois Cancer Specialists, Niles · 6 mi jauh
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Mengambil pesertaFasa 3
- Advocate Lutheran General Hospital, Park Ridge · 8 mi jauh
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Mengambil pesertaFasa 2
- Advocate Aurora Health, Park Ridge · 8 mi jauh
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi jauh
- Advocate Lutheran General Hospital, Park Ridge · 8 mi jauh
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi jauh
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2/3
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi jauh
- Advocate Lutheran General Hospital, Park Ridge · 8 mi jauh
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
Mengambil pesertaSukarelawan sihat dialu-alukan
- Northwestern University, Evanston
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Mengambil pesertaKajian pemerhatian
- Northshore University Health System, Evanston
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Mengambil pesertaKajian pemerhatian
- Advocate Lutheran General Hospital, Park Ridge · 8 mi jauh
Kajian Kanser Paru-paru di bandar lain
- Houston, TX78 kajian
- Boston, MA62 kajian
- New York City, NY60 kajian
- Los Angeles, CA45 kajian
- Washington, DC41 kajian
- Arlington, VA41 kajian
- Chicago, IL41 kajian
- Nashville, TN40 kajian
- Baltimore, MD40 kajian
- St. Louis, MO39 kajian
- Columbus, OH37 kajian
- Philadelphia, PA36 kajian
Kajian lain di Evanston
- Kanser Paru-paru Bukan Sel Kecil22 kajian
- Kanser Payudara13 kajian
- Leukemia Mieloid Akut11 kajian
- Obesiti11 kajian
- Kanser Kolorektal10 kajian
- Kanser (semua jenis)9 kajian
- Berat Badan Berlebihan9 kajian
- Kolitis Ulseratif9 kajian
- Kanser Prostat9 kajian
- Penyakit Crohn9 kajian
- Kegagalan Jantung8 kajian
- Fibrilasi Atrium8 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.